David Lebwohl insider trades

Open-market stock purchases and sales by David Lebwohl, EVP, Chief Medical Officer at Intellia Therapeutics, Inc, from SEC Form 4 filings since May 1, 2020.

Recent trades

DateStockTradeValue
Mar 1, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Mar 1, 2026NTLA Intellia Therapeutics, IncBought (not open market)—
Jan 5, 2026NTLA Intellia Therapeutics, IncSold$110K

Companies traded

  • NTLA Intellia Therapeutics, Inc: 21 sales, last Mar 1, 2026

Get free alerts when David Lebwohl files a new trade →